Clinical trial
GW406381 In Patients With Peripheral Nerve Injury
NCT00279032 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00279032 |
|---|---|
| Title | GW406381 In Patients With Peripheral Nerve Injury |
| Official title | A Randomised, Placebo-Controlled, Double-Blind, Parallel Group Study to Investigate the Effects of Chronic Dose Oral GW406381 on Pain and Areas of Hyperalgesia and Allodynia in Patients With Peripheral Nerve Injury as a Result of Trauma or Surgery. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Hyperalgesia, Neurodynia, Pain, Trauma |
| Intervention type | Drug |
| Interventions | GW406381 |
| Enrollment | 40 |
| Start date | Sep 1, 2003 |
| First posted | Jan 19, 2006 |
| Last update posted | Feb 23, 2009 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: